Used in pharmaceutical synthesis as an intermediate for bioactive compounds, particularly in the development of peptide-based drugs. Its structure supports the formation of stable cyclic motifs that enhance metabolic stability and binding affinity in drug candidates. Commonly employed in the preparation of protease inhibitors and other therapeutic agents targeting neurological and infectious diseases. Also utilized in research settings for designing novel molecules with improved pharmacokinetic properties.